Latest filings (excl ownership)
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
10-K
2023 FY
Annual report
22 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
20 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
DEF 14A
Definitive proxy
3 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
8-K
Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements
28 Jun 23
8-K
Creative Medical Technology Holdings Announces Reverse Stock Split
9 Jun 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
31 Mar 23
8-K
Submission of Matters to a Vote of Security Holders
19 Dec 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
DEF 14A
Definitive proxy
26 Oct 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
14 Jul 22
424B3
Prospectus supplement
20 May 22
EFFECT
Notice of effectiveness
20 May 22
CORRESP
Correspondence with SEC
17 May 22
UPLOAD
Letter from SEC
16 May 22
10-Q
2022 Q1
Quarterly report
13 May 22
S-3
Shelf registration
10 May 22
D
$17M in equity / options, sold $17M, 18 investors
5 May 22
RW
Registration withdrawal request
4 May 22
8-K
Entry into a Material Definitive Agreement
4 May 22
8-K
Entry into a Material Definitive Agreement
4 May 22
10-K/A
2021 FY
Annual report (amended)
29 Apr 22
S-1
IPO registration
22 Apr 22
10-K
2021 FY
Annual report
30 Mar 22
8-K
Departure of Directors or Certain Officers
11 Feb 22
8-K
Creative Medical Technology Holdings, Inc. Prices $16 Million Public Offering and Uplisting to the Nasdaq Capital Market
7 Dec 21
424B4
Prospectus supplement with pricing info
6 Dec 21
EFFECT
Notice of effectiveness
3 Dec 21
CERT
Certification of approval for exchange listing
2 Dec 21
8-A12B
Registration of securities on exchange
2 Dec 21
S-1/A
IPO registration (amended)
2 Dec 21
CORRESP
Correspondence with SEC
2 Dec 21
UPLOAD
Letter from SEC
2 Dec 21
S-1/A
IPO registration (amended)
1 Dec 21
CORRESP
Correspondence with SEC
30 Nov 21
Latest ownership filings
4
Timothy Warbington
29 Jun 23
SC 13G/A
Markey John
26 May 23
SC 13G
Markey John
1 May 23
4
Timothy Warbington
23 Nov 22
4
Michael H. Finger
29 Sep 22
4
Timothy Warbington
28 Sep 22
4
Timothy Warbington
22 Sep 22
4
Michael H. Finger
14 Jun 22
4
Timothy Warbington
7 Jun 22
4
Michael H. Finger
20 May 22
SC 13G/A
CVI Investments, Inc.
14 Feb 22
SC 13G/A
Altium Capital Management LP
14 Feb 22
SC 13G/A
L1 Capital Global Opportunities Master Fund, Ltd.
14 Feb 22
4
Timothy Warbington
11 Feb 22
4
Donald Dickerson
11 Feb 22
3
Susan H Snow
5 Jan 22
SC 13G
Altium Capital Management LP
20 Dec 21
3
Michael H. Finger
13 Dec 21
3
Bruce Steven Urdang
13 Dec 21
SC 13G
CVI Investments, Inc.
10 Dec 21
SC 13G
L1 Capital Global Opportunities Master Fund, Ltd.
8 Dec 21
4
Thomas Ichim
22 Jul 21
4
Amit Nilkanth Patel
16 Jul 21
4
Donald Dickerson
16 Jul 21
4
Thomas Ichim
16 Jul 21
4
Thomas Ichim
29 Jun 21
4
Timothy Warbington
8 Jan 21
4
Change in insider ownership
8 Jan 21
4
Donald Dickerson
31 Dec 20
4
Amit Nilkanth Patel
31 Dec 20
4
Thomas Ichim
31 Dec 20
4
Change in insider ownership
2 Oct 20
4
Timothy Warbington
2 Oct 20
4
Timothy Warbington
5 Jun 20
4
Change in insider ownership
5 Jun 20
4
Timothy Warbington
19 Feb 20
4
Change in insider ownership
19 Feb 20
4
Change in insider ownership
13 Dec 19
4
Timothy Warbington
13 Dec 19
4
Timothy Warbington
13 Dec 19